Healthcare Industry News: enCor
News Release - May 25, 2006
SenoRx Successfully Settles Lawsuit
ALISO VIEJO, Calif.--(HSMN NewsFeed)--May 25, 2006--SenoRx, Inc. today announced that it has reached a settlement agreement with Suros Surgical Systems related to a suit that Suros filed in the U.S. District Court for the Southern District of Indiana in February 2005. The suit filed by Suros alleged patent infringement by SenoRx of Suros' U.S. Patent No. 5,997,560.The litigation was resolved without admission of liability by either party and without any payments by either party. Under terms of the settlement, SenoRx agreed to remove the transverse slot from the cutter of its EnCor(TM) breast biopsy device.
Suros may reinstitute the litigation if SenoRx sells EnCor(TM) cutters with a transverse slot after October 31, 2006.
"We are pleased to have resolved this litigation without any interruption in supply of our enCor System to our customers. We have already been manufacturing and selling the modified enCor cutter in commercial quantities throughout 2006 and we do not believe the modification has any impact on the enCor device," stated Lloyd H. Malchow, President and CEO.
About SenoRx, Inc.
SenoRx was founded in 1998 to develop, manufacture and sell minimally-invasive devices for the diagnosis and treatment of breast cancer. SenoRx is focused on developing and offering a broad portfolio of products that address needs across the continuum of breast care.
Source: SenoRx
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!